Accuray September 11th, 2024
September 11th 2024, 7am PDT | 10am EDT | 4pm CEST | 7.30pm IST | 10pm HKT
Presenters: Vedang Murthy, M.D., DNB, DipEPP, Tata Memorial Centre, Mumbai, India
Moderator: Seth Blacksburg, M.D., MBA, Senior Vice President, Chief Medical Officer, Accuray
Summary: The webinar’s learning objectives include:
- Understanding the role of Whole Pelvic Radiotherapy (WPRT) in Prostate Cancer Treatment, including its potential to enhance survival and its rationale in treating both node-negative and node-positive prostate cancer patients.
- Evaluating WPRT Optimization with Advanced Imaging Techniques, such as the role of PSMA PET CT in refining WPRT for node-positive prostate cancer and the influence of contemporary imaging on radiation treatment planning and outcomes.
- Analyzing Clinical Trial Outcomes on Pelvic Radiotherapy, including a review of pivotal trial results comparing pelvic irradiation to prostate-only irradiation and summarizing long-term survival data and clinical practice implications.
- Comparing Radiotherapy Techniques and Their Effectiveness, contrasting the efficacy and side effect profiles of different radiotherapy techniques in prostate cancer treatment and discussing the practicality and safety of SBRT in node-positive prostate cancer.
DISCLAIMER: The statements and articles in the corporate news forum do not necessarily reflect the views of, and are not endorsed by ISRS. Please consult the specific corporate entity for relevant disclosures and restrictions related to these news features.